Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.0850
0.00 (0.00%)
Oct 9, 2026, 3:35 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 29.26 million as of October 9, 2026. It is the 36,988th most valuable company in the world and the 1,186th biggest in Canada. Its market cap has decreased by 2.88% in one year.
Market Cap
29.26M
Enterprise Value
159.02M
Revenue
n/a
Global Rank
Country Rank
#1,186 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 29.26M, an increase of 27.57%. That is a compound annual growth rate of 1.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 29.26M | 1.77% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 42.46M |
| Medicenna Therapeutics | 40.61M |
| Sona Nanotech | 38.68M |
| Thiogenesis Therapeutics | 34.29M |
| Telescope Innovations | 33.95M |
| The More Life Company | 29.71M |
| Defence Therapeutics | 28.80M |
| Pharmala Biotech Holdings | 23.58M |